Marcio Souza - Aug 25, 2022 Form 4 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
Director
Signature
/s/ James Kastenmayer, by power of attorney
Stock symbol
AGLE
Transactions as of
Aug 25, 2022
Transactions value $
$50,472
Form type
4
Date filed
8/25/2022, 07:37 PM
Previous filing
Jun 24, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGLE Common Stock Purchase $50.5K +90K $0.56 90K Aug 25, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.